BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36243040)

  • 41. Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
    Sarris AH; Luthra R; Papadimitracopoulou V; Waasdorp M; Dimopoulos MA; McBride JA; Cabanillas F; Duvic M; Deisseroth A; Morris SW; Pugh WC
    Blood; 1996 Sep; 88(5):1771-9. PubMed ID: 8781434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synergistic Effect of Alectinib and Everolimus on ALK-positive Anaplastic Large Cell Lymphoma Growth Inhibition.
    Kim D; Koh Y; Yoon SS
    Anticancer Res; 2020 Mar; 40(3):1395-1403. PubMed ID: 32132036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma.
    Merkel O; Hamacher F; Laimer D; Sifft E; Trajanoski Z; Scheideler M; Egger G; Hassler MR; Thallinger C; Schmatz A; Turner SD; Greil R; Kenner L
    Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16228-33. PubMed ID: 20805506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma.
    Liu C; Iqbal J; Teruya-Feldstein J; Shen Y; Dabrowska MJ; Dybkaer K; Lim MS; Piva R; Barreca A; Pellegrino E; Spaccarotella E; Lachel CM; Kucuk C; Jiang CS; Hu X; Bhagavathi S; Greiner TC; Weisenburger DD; Aoun P; Perkins SL; McKeithan TW; Inghirami G; Chan WC
    Blood; 2013 Sep; 122(12):2083-92. PubMed ID: 23801630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skin involvement as the first symptom of rapidly progressive ALK-positive systemic anaplastic large cell lymphoma.
    Yu X; Zhang J; Xu K; Li M; Yao Z
    Clin Exp Dermatol; 2017 Jul; 42(5):539-542. PubMed ID: 28556361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anaplastic large cell lymphoma, ALK-negative.
    Ferreri AJ; Govi S; Pileri SA; Savage KJ
    Crit Rev Oncol Hematol; 2013 Feb; 85(2):206-15. PubMed ID: 22789917
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary systemic anaplastic large cell lymphoma in Korean adults: 11 years' experience at Asan Medical Center.
    Park SJ; Kim S; Lee DH; Jeong YP; Bae Y; Han EM; Huh J; Suh C
    Yonsei Med J; 2008 Aug; 49(4):601-9. PubMed ID: 18729302
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The biology and management of systemic anaplastic large cell lymphoma.
    Hapgood G; Savage KJ
    Blood; 2015 Jul; 126(1):17-25. PubMed ID: 25869285
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Leukemic phase of anaplastic lymphoma kinase positive, anaplastic large cell lymphoma.
    Gadage VS; Subramanian PG; Galani KS; Sehgal KK; Johari SP; Ghogale VS; Badrinath Y; Ashok K; Gujral S
    Indian J Pathol Microbiol; 2011; 54(3):599-602. PubMed ID: 21934233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A case of primary central nervous system anaplastic lymphoma kinase positive anaplastic large cell lymphoma manifested as a unilateral pachymeningits].
    Fujisawa E; Shibayama H; Mitobe F; Katada F; Sato S; Fukutake T
    Rinsho Shinkeigaku; 2017 Nov; 57(11):705-710. PubMed ID: 29070753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group study.
    Cederleuf H; Bjerregård Pedersen M; Jerkeman M; Relander T; d'Amore F; Ellin F
    Br J Haematol; 2017 Sep; 178(5):739-746. PubMed ID: 28485010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anaplastic large cell lymphoma: a single institution experience from India.
    Lakshmaiah KC; Guruprasad B; Shah A; Kavitha S; Abraham LJ; Govindbabu K; Aruna Kumari BS; Appaji L
    J Cancer Res Ther; 2013; 9(4):649-52. PubMed ID: 24518711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The clinicopathological relevance of uniform CD56 expression in anaplastic large cell lymphoma: a retrospective analysis of 18 cases.
    Yu BH; Zhang Y; Xue T; Shui RH; Lu HF; Zhou XY; Zhu XZ; Li XQ
    Diagn Pathol; 2021 Jan; 16(1):1. PubMed ID: 33402163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The anaplastic lymphoma kinase controls cell shape and growth of anaplastic large cell lymphoma through Cdc42 activation.
    Ambrogio C; Voena C; Manazza AD; Martinengo C; Costa C; Kirchhausen T; Hirsch E; Inghirami G; Chiarle R
    Cancer Res; 2008 Nov; 68(21):8899-907. PubMed ID: 18974134
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary central nervous system ALK-positive anaplastic large cell lymphoma with CD56 abnormally expression in a Chinese child: Challenge in diagnostic practice.
    Liu Q; Chen X; Li G; Ye Y; Liu W; Zhao S; Zhang W
    Int J Immunopathol Pharmacol; 2020; 34():2058738420941756. PubMed ID: 32664812
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Successful long-term control of recurrent primary central nervous system anaplastic large cell lymphoma after autologous hematopoietic stem cell transplantation with concurrent whole brain and spinal cord radiotherapy].
    Hiroshima Y; Kaiume H; Kirihara T; Takeda W; Kurihara T; Sato K; Shimizu I; Ueki T; Sumi M; Ueno M; Ichikawa N; Asano N; Watanabe M; Kobayashi H
    Rinsho Ketsueki; 2015 Dec; 56(12):2477-82. PubMed ID: 26725359
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.
    Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L
    Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sarcomatoid variant of ALK- anaplastic large cell lymphoma involving multiple lymph nodes and both lungs with production of proinflammatory cytokines: report of a case and review of literature.
    Yu L; Yan LL; Yang SJ
    Int J Clin Exp Pathol; 2014; 7(8):4806-16. PubMed ID: 25197351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
    Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM
    Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systemic and primary cutaneous anaplastic large cell lymphomas.
    Kadin ME; Carpenter C
    Semin Hematol; 2003 Jul; 40(3):244-56. PubMed ID: 12876673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.